Table 2: Demographics and clinical characteristics
| Age (yr) | 73 ± 17 | |
| Male (%) | 63% | |
| DM (%) | 37% | |
| Hypertension (%) | 89% | |
| Extracardiac arteriopathy | 8 (21%) | |
| Serum Cr>200mcg/dL | 3(8%) | |
| neurodysfunction | 5 (13%) | |
| Prior CABG | 10 (26%) | |
| Stable angina | 16 (42%) | |
| NSTEMI/UAP | 15 (39%) | |
| STEMI | 7 (18%) | |
| Shock | 2 (5%) | |
| EuroSCORE (l) | Logistics | 17.7 ± 19.1% (range0.88-85.8%) |
| Additive | 8.2 ± 4.7 (range 0-19) | |
| LVEF (%) | 54 ± 13% | (25-75%) |
| IABP use | 4 (11%) |